Enteric fever in a UK regional infectious diseases unit: A 10 year retrospective review

Journal of Infection

Volumn 60, Issue 2, 2010, Pages 91-98

  Clark, Tristan W ^a   Daneshvar, Cyrus ^b   Pareek, Manish ^a   Perera, Nelun ^a   Stephenson, Iain ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

Paratyphoid; Returning travellers; Typhoid

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; TRIMETHOPRIM;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ETHNICITY; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELAPSE; RETROSPECTIVE STUDY; SYMPTOM; TRAVEL; TYPHOID FEVER; UNITED KINGDOM; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GREAT BRITAIN; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SALMONELLA TYPHI; TRAVEL; TYPHOID FEVER; YOUNG ADULT;

EID: 75549090284     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.11.009     Document Type: Article

References (28)

1. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004 May, 82(5):346-353.
2. Sinha A., Sazawal S., Kumar R., Sood S., Reddaiah V.P., Singh B., et al. Typhoid fever in children aged less than 5 years. Lancet 1999 Aug 28, 354(9180):734-737.
3. Health Protection Agency Pilot of enhanced surveillance of enteric fever in England, Wales, and Northern Ireland, 1 May 2006 to 30 April 2007 March 2008, Health Protection Agency, London.
4. Connor B.A., Schwartz E. Typhoid and paratyphoid fever in travelers. Lancet Infect Dis 2005 Oct, 5(10):623-628.
5. Caumes E., Ehya N., Nguyen J., Bricaire F. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001 Nov, 8(6):293-297.
6. Jelinek T., Nothfurft H.D., Sonnenburg F.V., Loscher T. Risk factors for typhoid fever in travelers. J Travel Med 1996 Dec, 3(4):200-203.
7. Meltzer E., Sadik C., Schwartz E. Enteric fever in Israeli travelers: a nationwide study. J Travel Med 2005 Sep, 12(5):275-281.
8. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N Engl J Med 2002 Nov 28, 347(22):1770-1782.
9. Threlfall E.J., Ward L.R. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001, 7(3):448-450.
10. Slinger R., Desjardins M., McCarthy A.E., Ramotar K., Jessamine P., Guibord C., et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004 Sep 20, 4:36.
11. Maskey A.P., Basnyat B., Thwaites G.E., Campbell J.I., Farrar J.J., Zimmerman M.D. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg 2008 Jan, 102(1):91-95.
12. Crump J.A., Barrett T.J., Nelson J.T., Angulo F.J. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003 Jul 1, 37(1):75-81.
13. Crump J.A., Kretsinger K., Gay K., Hoekstra R.M., Vugia D.J., Hurd S., et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 2008 Apr, 52(4):1278-1284.
14. Pandit A., Arjyal A., Day J.N., Paudyal B., Dangol S., Zimmerman M.D., et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2007 Jun 27, 2(6):e542.
15. Dolecek C., Tran T.P., Nguyen N.R., Le T.P., Ha V., Phung Q.T., et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS ONE 2008 May 21, 3(5):e2188.
16. Butler T., Sridhar C.B., Daga M.K., Pathak K., Pandit R.B., Khakhria R., et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999 Aug, 44(2):243-250.
17. Census Office for national statistics 2001, http://www.statistics.gov.uk.
18. Fraser A., Paul M., Goldberg E., Acosta C.J., Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007 Nov 7, 25(45):7848-7857.
19. Nic Fhogartaigh C., Hughes H., Armstrong M., Herbert S., McGregor A., Ustianowski A., et al. Falciparum malaria as a cause of fever in adult travelers returning to the United Kingdom: observational study of risk by geographical area. QJM 2008 Aug, 101(8):649-656.
20. Stephenson I., Roper J., Fraser M., Nicholson K., Wiselka M. Dengue fever in febrile returning travellers to a UK regional infectious diseases unit. Travel Med Infect Dis 2003 May, 1(2):89-93.
21. Kuvandik C., Karaoglan I., Namiduru M., Baydar I. Predictive value of clinical and laboratory findings in the diagnosis of enteric fever. New Microbiol 2009 Jan, 32(1):25-30.
22. Stuart B.M., Pullen R.L. Typhoid: clinical analysis of three hundred and sixty cases. Arch Intern Med 1946, 78(6):629-666.
23. Bottieau E., Clerinx J., Van den Enden E., Van Esbroeck M., Colebunders R., Van Gompel A., et al. Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions. Medicine (Baltimore) 2007 Jan, 86(1):18-25.
24. Robinson P., Jenney A.W., Tachado M., Yung A., Manitta J., Taylor K., et al. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med 2001, 8(2):76-81.
25. Maskey A.P., Day J.N., Tuan P.Q., Thwaites G.E., Campbell J.I., Zimmerman M., et al. Salmonella enterica Serovar Paratyphi A and S. enterica Serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006 May 1, 42(9):1247-1253.
26. Wain J., Diep T.S., Ho V.A., Walsh A.M., Nguyen T.T., Parry C.M., et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998 Jun, 36(6):1683-1687.
27. Effa E.E., Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008 Oct 8, 4:CD006083.
28. Cooke F.J., Day M., Wain J., Ward L.R., Threlfall E.J. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003). Trans R Soc Trop Med Hyg 2007 Apr, 101(4):398-404.